secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aldeyra Therapeutics, Inc. (ALDX)
CIK:        0001341235
Form:       8-K
Filed at:   2026-04-20T23:59:59+00:00
Accession:  0001193125-26-164198
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Martin J. Joyce will not stand for re-election at 2026 annual meeting
------------------------------------------------------------------------------

- Martin J. Joyce notified Aldeyra on April 20, 2026 of his decision not to stand for re-election.
- His term will expire at the upcoming 2026 annual meeting of stockholders.
- The decision was not the result of any disagreement with Aldeyra.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1341235/000119312526164198/0001193125-26-164198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1341235/000119312526164198/aldx-20260420.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-164198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer